Evonik acquires hydrogen peroxide plant in Ontario
By Canadian Packaging Staff
General cellulose Evonik hydrogen peroxide Kemira Chemicals Canada PaperGerman company takes over Kemira Chemicals Canada to supplement cellulose and paper industry concerns.
Germany-based Evonik Industries has closed the deal to take over the hydrogen peroxide business from Kemira Chemicals Canada Inc. effective December 1, 2011 covering its Maitland, Ont. production plant plus the seller’s customer portfolio, with the Canadian employees also being transferred to Evonik.
“This transaction sees us taking another step in our global growth strategy for hydrogen peroxide,” explains Jan Van den Bergh, head of Advanced Intermediates, the business unit in charge of the hydrogen peroxide business at Evonik. “Our growth strategy is based on new technologies, as is exemplified by our deal in Jilin, China, where we will be supplying H2O2 (hydrogen peroxide) to a plant specializing in the chemical direct synthesis of propylene oxide, and by targeted acquisitions like this one in Canada.”
The production operations in Maitland will primarily provide supplies of hydrogen peroxide, an eco-friendly oxidation agent, to the North American cellulose and paper industry.
This new acquisition puts Evonik among the market leaders of hydrogen peroxide suppliers to the North American market (Canada and the U.S.). The takeover enables Evonik to increase its capacities for hydrogen peroxide production in N.A. by 44,000 metric tons to more than 200,000 metric tons per annum. The Group already runs local hydrogen peroxide production sites in Gibbons, Alberta and Mobile, Alabama.
About Evonik
Evonik is a global leader in specialty chemicals. Its activities focus on the key megatrends health, nutrition, resource efficiency and globalization. Evonik is active in over 100 countries around the world with over 34,000 employees. In fiscal 2010, it generated sales of around €13.3 billion (~Cdn/US $18-billion) and an operating profit (EBITDA) of about €2.4 billion (~Cdn?US $3.25-billion).
For more information about it’s N.A. concerns, visit http://north-america.evonik.com/region/north_america/en/Pages/default.aspx.
Advertisement
